The following data is part of a premarket notification filed by Dade Behring, Inc. with the FDA for Modification To N/t Rheumatology Controls Sl 1 & 2.
Device ID | K021381 |
510k Number | K021381 |
Device Name: | MODIFICATION TO N/T RHEUMATOLOGY CONTROLS SL 1 & 2 |
Classification | Multi-analyte Controls, All Kinds (assayed) |
Applicant | DADE BEHRING, INC. 514 GBC DR. Newark, DE 19702 |
Contact | Donna A Wolf |
Correspondent | Donna A Wolf DADE BEHRING, INC. 514 GBC DR. Newark, DE 19702 |
Product Code | JJY |
CFR Regulation Number | 862.1660 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2002-05-01 |
Decision Date | 2002-06-10 |
Summary: | summary |
Device Identifier | submissionNumber | Supplement |
---|---|---|
00842768007279 | K021381 | 000 |
00842768007262 | K021381 | 000 |
00630414287423 | K021381 | 000 |
00630414287416 | K021381 | 000 |